The characterization of the caenorhabditis elegans mitochondrial thioredoxin system uncovers an unexpected protective role of thioredoxin reductase 2 in β-Amyloid peptide toxicity

Antioxidants and Redox Signaling

Volumn 16, Issue 12, 2012, Pages 1384-1400

  Cacho Valadez, Briseida ^a   Muñoz Lobato, Fernando ^a   Pedrajas, José Rafael ^b   Cabello, Juan ^c   Fierro González, Juan Carlos ^d   Navas, Plácido ^a,e   Swoboda, Peter ^d   Link, Chris D ^f   Miranda Vizuete, Antonio ^a,g  

^a Universidad Pablo de Olavide   (Spain)

^b UNIVERSITY OF JAÉN   (Spain)

^c CENTER FOR BIOMEDICAL RESEARCH OF LA RIOJA CIBIR   (Spain)

^d KAROLINSKA INSTITUTE   (Sweden)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f UNIVERSITY OF COLORADO   (United States)

^g HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; REACTIVE OXYGEN METABOLITE; THIOREDOXIN 2; THIOREDOXIN REDUCTASE 2;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; ENZYME INDUCTION; ENZYME LOCALIZATION; GENE OVEREXPRESSION; MITOCHONDRION; MUTANT; NONHUMAN; PARALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN UNFOLDING; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; WILD TYPE;

AMYLOID BETA-PEPTIDES; ANIMALS; ANIMALS, GENETICALLY MODIFIED; APOPTOSIS; CAENORHABDITIS ELEGANS; HUMANS; MITOCHONDRIA; REAL-TIME POLYMERASE CHAIN REACTION; THIOREDOXIN REDUCTASE 2; THIOREDOXINS; UNFOLDED PROTEIN RESPONSE;

EID: 84860147700     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4265     Document Type: Article

References (60)

1. Artal-Sanz M, Tsang WY, Willems EM, Grivell LA, Lemire BD, van der Spek H, and Nijtmans LG. The mitochondrial prohibitin complex is essential for embryonic viability and germline function in Caenorhabditis elegans. J Biol Chem 278: 32091-32099, 2003. (Pubitemid 37048398)
2. Bates KA, Verdile G, Li QX, Ames D, Hudson P, Masters CL, and Martins RN. Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests. Mol Psychiatry 14: 469-486, 2009.
3. Bukau B, Weissman J, and Horwich A. Molecular chaperones and protein quality control. Cell 125: 443-451, 2006.
4. Chen Q, Vazquez EJ, Moghaddas S, Hoppel CL, and Lesnefsky EJ. Production of reactive oxygen species by mitochondria: central role of complex III. J Biol Chem 278: 36027-36031, 2003. (Pubitemid 37139922)
5. Chen Y, Cai J, and Jones DP. Mitochondrial thioredoxin in regulation of oxidant-induced cell death. FEBS Lett 580: 6596-6602, 2006. (Pubitemid 44830129)
6. Cohen E, Du D, Joyce D, Kapernick EA, Volovik Y, Kelly JW, and Dillin A. Temporal requirements of insulin/IGF-1 signaling for proteotoxicity protection. Aging Cell 9: 126-134, 2010.
7. Conrad M, Jakupoglu C, Moreno SG, Lippl S, Banjac A, Schneider M, Beck H, Hatzopoulos AK, Just U, Sinowatz F, Schmahl W, Chien KR, Wurst W, Bornkamm GW, and Brielmeier M. Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function. Mol Cell Biol 24: 9414-9423, 2004. (Pubitemid 39391679)
8. D'Autreaux B and Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 8: 813-824, 2007. (Pubitemid 47462134)
9. Dai S, He Y, Zhang H, Yu L, Wan T, Xu Z, Jones D, Chen H, and Min W. Endothelial-specific expression of mitochondrial thioredoxin promotes ischemia-mediated arteriogenesis and angiogenesis. Arterioscler Thromb Vasc Biol 29: 495-502, 2009.
10. Damdimopoulos AE, Miranda-Vizuete A, Pelto-Huikko M, Gustafsson JA, and Spyrou G. Human mitochondrial thioredoxin. Involvement in mitochondrial membrane potential and cell death. J Biol Chem 277: 33249-33257, 2002. (Pubitemid 34984845)
11. Eklund H, Gleason FK, and Holmgren A. Structural and functional relations among thioredoxins of different species. Proteins 11: 13-28, 1991.
12. Fernando MR, Lechner JM, Lofgren S, Gladyshev VN, and Lou MF. Mitochondrial thioltransferase (glutaredoxin 2) has GSH-dependent and thioredoxin reductase-dependent peroxidase activities in vitro and in lens epithelial cells. FASEB J 20: 2645-2647, 2006.
13. Florez-McClure ML, Hohsfield LA, Fonte G, Bealor MT, and Link CD. Decreased insulin-receptor signaling promotes the autophagic degradation of beta-amyloid peptide in C. elegans. Autophagy 3: 569-580, 2007. (Pubitemid 350060053)
14. Fonte V, Dostal V, Roberts CM, Gonzales P, Lacor P, Magrane J, Dingwell N, Fan EY, Silverman MA, Stein GH, and Link CD. A glycine zipper motif mediates the formation of toxic beta-amyloid oligomers in vitro and in vivo. Mol Neurodegener 6: 61, 2011.
15. Fonte V, Kipp DR, Yerg J 3rd, Merin D, Forrestal M, Wagner E, Roberts CM, and Link CD. Suppression of in vivo betaamyloid peptide toxicity by overexpression of the HSP-16.2 small chaperone protein. J Biol Chem 283: 784-791, 2008.
16. Gladyshev VN, Krause M, Xu XM, Korotkov KV, Kryukov GV, Sun QA, Lee BJ, Wootton JC, and Hatfield DL. Selenocysteinecontaining thioredoxin reductase in C. elegans. Biochem Biophys Res Commun 259: 244-249, 1999.
17. Gumienny TL, Lambie E, Hartwieg E, Horvitz HR, and Hengartner MO. Genetic control of programmed cell death in the Caenorhabditis elegans hermaphrodite germline. Development 126: 1011-1022, 1999. (Pubitemid 29142008)
18. Hanschmann EM, Lonn ME, Schutte LD, Funke M, Godoy JR, Eitner S, Hudemann C, and Lillig CH. Both thioredoxin 2 and glutaredoxin 2 contribute to the reduction of the mitochondrial 2-Cys peroxiredoxin Prx3. J Biol Chem 285: 40699-40705, 2010.
19. Hansen JM, Zhang H, and Jones DP. Mitochondrial thioredoxin-2 has a key role in determining tumor necrosis factoralpha-induced reactive oxygen species generation,NF-kappaB activation, and apoptosis. Toxicol Sci 91: 643-650, 2006. (Pubitemid 43827316)
20. Holmgren A and Bjornstedt M. Thioredoxin and thioredoxin reductase. Methods Enzymol 252: 199-208, 1995.
21. Huang P, Pleasance ED, Maydan JS, Hunt-Newbury R, O'Neil NJ, Mah A, Baillie DL, Marra MA, Moerman DG, and Jones SJ. Identification and analysis of internal promoters in Caenorhabditis elegans operons. Genome Res 17: 1478-1485, 2007. (Pubitemid 47529432)
22. Johansson C, Lillig CH, and Holmgren A. Human mitochondrial glutaredoxin reduces S-glutathionylated proteins with high affinity accepting electrons from either glutathione or thioredoxin reductase. J Biol Chem 279: 7537-7543, 2004. (Pubitemid 38294632)
23. Kao AW, Eisenhut RJ, Martens LH, Nakamura A, Huang A, Bagley JA, Zhou P, de Luis A, Neukomm LJ, Cabello J, Farese RV Jr., and Kenyon C. A neurodegenerative disease mutation that accelerates the clearance of apoptotic cells. Proc Natl Acad Sci USA 108: 4441-4446, 2011.
24. Kenyon CJ. The genetics of ageing. Nature 464: 504-512, 2010.
25. Kim MR, Chang HS, Kim BH, Kim S, Baek SH, Kim JH, Lee SR, and Kim JR. Involvements of mitochondrial thioredoxin reductase (TrxR2) in cell proliferation. Biochem Biophys Res Commun 304: 119-124, 2003. (Pubitemid 36434204)
26. Kirstein-Miles J and Morimoto RI. Caenorhabditis elegans as a model system to study intercompartmental proteostasis: interrelation of mitochondrial function, longevity, and neurodegenerative diseases. Dev Dyn 239: 1529-1538, 2010.
27. Koehler CM, Beverly KN, and Leverich EP. Redox pathways of the mitochondrion. Antioxid Redox Signal 8: 813-822, 2006. (Pubitemid 44036499)
28. Kowaltowski AJ, de Souza-Pinto NC, Castilho RF, and Vercesi AE. Mitochondria and reactive oxygen species. Free Radic Biol Med 47: 333-343, 2009.
29. Lacey BM and Hondal RJ. Characterization of mitochondrial thioredoxin reductase from C. elegans. Biochem Biophys Res Commun 346: 629-636, 2006.
30. Larsen PL, Albert PS, and Riddle DL. Genes that regulate both development and longevity in Caenorhabditis elegans. Genetics 139: 1567-1583, 1995.
31. Link CD. Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc Natl Acad Sci USA 92: 9368-9372, 1995.
32. Link CD. C. elegans models of age-associated neurodegenerative diseases: lessons from transgenic worm models of Alzheimer's disease. Exp Gerontol 41: 1007-1013, 2006. (Pubitemid 44821699)
33. Link CD, Johnson CJ, Fonte V, Paupard M, Hall DH, Styren S, Mathis CA, and Klunk WE. Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34. Neurobiol Aging 22: 217-226, 2001. (Pubitemid 32162970)
34. Link CD, Taft A, Kapulkin V, Duke K, Kim S, Fei Q, Wood DE, and Sahagan BG. Gene expression analysis in a transgenic Caenorhabditis elegans Alzheimer's disease model. Neurobiol Aging 24: 397-413, 2003. (Pubitemid 36205048)
35. Meyer Y, Buchanan BB, Vignols F, and Reichheld JP. Thioredoxins and glutaredoxins: unifying elements in redox biology. Annu Rev Genet 43: 335-367, 2009.
36. Miranda-Vizuete A, Damdimopoulos AE, and Spyrou G. The mitochondrial thioredoxin system. Antioxid Redox Signal 2: 801-810, 2000. (Pubitemid 32063256)
37. Missirlis F, Ulschmid JK, Hirosawa-Takamori M, Gronke S, Schafer U, Becker K, Phillips JP, and Jackle H. Mitochondrial and cytoplasmic thioredoxin reductase variants encoded by a single Drosophila gene are both essential for viability. J Biol Chem 277: 11521-11526, 2002. (Pubitemid 34952922)
38. Nalvarte I, Damdimopoulos AE, Nystom C, Nordman T, Miranda-Vizuete A, Olsson JM, Eriksson L, Bjornstedt M, Arner ES, and Spyrou G. Overexpression of enzymatically active human cytosolic and mitochondrial thioredoxin reductase in HEK-293 cells. Effect on cell growth and differentiation. J Biol Chem 279: 54510-54517, 2004. (Pubitemid 40053192)
39. Nieto C, Almendinger J, Gysi S, Gomez-Orte E, Kaech A, Hengartner MO, Schnabel R, Moreno S, and Cabello J. ccz-1 mediates the digestion of apoptotic corpses in C. elegans. J Cell Sci 123: 2001-2007, 2010.
40. Nonn L, Williams RR, Erickson RP, and Powis G. The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice. Mol Cell Biol 23: 916-922, 2003. (Pubitemid 36133510)
41. Oka T, Toyomura T, Honjo K, Wada Y, and Futai M. Four subunit a isoforms of Caenorhabditis elegans vacuolar H+-ATPase. Cell-specific expression during development. J Biol Chem 276: 33079-33085, 2001.
42. Patenaude A, Ven Murthy MR, and Mirault ME. Mitochondrial thioredoxin system: effects of TrxR2 overexpression on redox balance, cell growth, and apoptosis. J Biol Chem 279: 27302-27314, 2004. (Pubitemid 38812570)
43. Pedrajas JR, Kosmidou E, Miranda-Vizuete A, Gustafsson JA, Wright AP, and Spyrou G. Identification and functional characterization of a novel mitochondrial thioredoxin system in Saccharomyces cerevisiae. J Biol Chem 274: 6366-6373, 1999. (Pubitemid 29111050)
44. Perez VI, Lew CM, Cortez LA, Webb CR, Rodriguez M, Liu Y, Qi W, Li Y, Chaudhuri A, Van Remmen H, Richardson A, and Ikeno Y. Thioredoxin 2 haploinsufficiency in mice results in impaired mitochondrial function and increased oxidative stress. Free Radic Biol Med 44: 882-892, 2008.
45. Pizzo P and Pozzan T. Mitochondria-endoplasmic reticulum choreography: structure and signaling dynamics. Trends Cell Biol 17: 511-517, 2007. (Pubitemid 47562768)
46. Psarra AM, Hermann S, Panayotou G, and Spyrou G. Interaction of mitochondrial thioredoxin with glucocorticoid receptor and NF-kappaB modulates glucocorticoid receptor and NF-kappaB signalling in HEK-293 cells. Biochem J 422: 521-531, 2009.
47. Reddien PW and Horvitz HR. CED-2/CrkII and CED-10/Rac control phagocytosis and cell migration in Caenorhabditis elegans. Nat Cell Biol 2: 131-136, 2000.
48. Rundlö f AK, Janard M, Miranda-Vizuete A, and Arner ESJ. Evidence for intriguinly complex transcription of human thioredoxin reductase 1. Free Radic Biol Med 36: 641-656, 2004. (Pubitemid 38230180)
49. Sies H and Jones DP. Oxidative stress. In: Encyclopedia of Stress, edited by Fink G. San Diego, CA: Elsevier, 2007, pp. 45-48.
50. Stanley BA, Sivakumaran V, Shi S, McDonald I, Lloyd D, Watson WH, Aon MA, and Paolocci N. Thioredoxin reductase-2 is essential for keeping low levels of H2O2 emission from isolated heart mitochondria. J Biol Chem 286: 33669-33677, 2011.
51. Stenvall J, Fierro-Gonzalez JC, Swoboda P, Saamarthy K, Cheng Q, Cacho-Valadez B, Arner ES, Persson OP, Miranda-Vizuete A, and Tuck S. Selenoprotein TRXR-1 and GSR-1 are essential for removal of old cuticle during molting in Caenorhabditis elegans. Proc Natl Acad Sci USA 108: 1064-1069, 2011.
52. Sulston J and Hodgkin J. Methods. In: The Nematode Caenorhabditis elegans, edited by Wood WB. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, 1988, pp. 587-606.
53. Sulston JE and Horvitz HR. Post-embryonic cell lineages of the nematode, Caenorhabditis elegans. Dev Biol 56: 110-156, 1977. (Pubitemid 8049332)
54. Sulston JE, Schierenberg E, White JG, and Thomson JN. The embryonic cell lineage of the nematode Caenorhabditis elegans. Dev Biol 100: 64-119, 1983.
55. Tanaka T, Hosoi F, Yamaguchi-Iwai Y, Nakamura H, Masutani H, Ueda S, Nishiyama A, Takeda S, Wada H, Spyrou G, and Yodoi J. Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis. EMBO J 21: 1695-1703, 2002. (Pubitemid 34614625)
56. Taylor EB and Rutter J. Mitochondrial quality control by the ubiquitin-proteasome system. Biochem Soc Trans 39: 1509-1513, 2011.
57. Timmons L, Court DL, and Fire A. Ingestion of bacterially expressed dsRNAs can produce specific and potent genetic interference in Caenorhabditis elegans. Gene 263: 103-112, 2001. (Pubitemid 32167059)
58. Trotter EW and Grant CM. Overlapping roles of the cytoplasmic and mitochondrial redox regulatory systems in the yeast Saccharomyces cerevisiae. Eukaryot Cell 4: 392-400, 2005. (Pubitemid 40257138)
59. Yoneda T, Benedetti C, Urano F, Clark SG, Harding HP, and Ron D. Compartment-specific perturbation of protein handling activates genes encoding mitochondrial chaperones. J Cell Sci 117: 4055-4066, 2004. (Pubitemid 39328294)
60. Zhang H, Go YM, and Jones DP. Mitochondrial thioredoxin-2/peroxiredoxin-3 system functions in parallel with mitochondrial GSH system in protection against oxidative stress. Arch Biochem Biophys 465: 119-126, 2007. (Pubitemid 47283985)